Wave Life Sciences WVE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's shares (diluted)?
- Wave Life Sciences (WVE) reported shares (diluted) of 200.2M in Q1 2026.
- How has Wave Life Sciences's shares (diluted) changed year-over-year?
- Wave Life Sciences's shares (diluted) increased by 23.1% year-over-year, from 162.6M to 200.2M.
- What is the long-term trend for Wave Life Sciences's shares (diluted)?
- Over 4 years (2021 to 2025), Wave Life Sciences's shares (diluted) has grown at a 34.7% compound annual growth rate (CAGR), from 201.6M to 662.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.